LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

LivaNova PLC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$78.14+0.56 (+0.72%)

Close on Oct 19, 2026

Market cap: $4.40B
P/E (TTM): 23.1
Dividend yield: –

LivaNova PLC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2015 2015-04-24	FY 2014 2014-04-25	FY 2013 2013-04-26
Revenue	1,388	1,253	1,154	1,022	1,035	934	1,084	1,107	1,012	292	282	254
Cost of Revenue	448	400	398	315	329	339	360	361	353	27	27	22
Gross Profit	940	853	756	707	706	595	724	746	652	264	255	232
Research & Development	186	183	194	156	183	153	147	146	110	42	45	42
Selling, General & Admin	549	509	503	469	472	447	528	465	380	124	121	113
Operating Expenses	–	–	–	–	–	–	–	–	556	176	175	154
Operating Income	199	129	-68	-77	-0.78	-274	-172	-248	96	89	80	78
Interest Expense	49	63	59	48	50	41	15	9.83	7.80	0.02	0.02	0.12
Interest & Investment Income	19	30	22	4.70	0.44	0.13	0.80	0.85	1.32	0.18	0.18	0.08
Income from Equity Investments	-0.05	-0.02	-0.10	-0.05	-0.15	-0.26	0	-0.64	-17	0	0	0
Other Non-Operating Income	-2.68	48	46	0.69	–	–	–	–	–	–	–	–
Merger & Restructuring Charges	-0.18	13	0.96	6.61	9.71	0	0	16	17	0	0	0
Asset Impairment Charges	–	0	0	129	0	21	42	0	0	0	0	–
Gain (Loss) on Investments	-3.62	7.14	0	0	4.64	0	0	–	–	–	–	–
Gain (Loss) on Sale of Assets	4.13	0	0	–	–	–	-3.22	-0.57	-5.98	0	0	0
Legal Settlements	–	–	–	–	–	–	–	–	–	0	-7.44	0
Pretax Income	-221	88	-81	-75	-124	-348	-188	-247	121	89	80	75
Income Tax Expense	22	25	-99	11	11	-0.96	-30	-70	50	31	25	29
Income from Continuing Operations	–	–	–	-86	-136	-347	-158	-178	54	58	–	–
Income from Discontinued Operations	–	–	–	0	0	-1.49	0.37	-11	-80	0	–	–
Net Income	-242	63	18	-86	-136	-349	-158	-189	-25	58	55	46
EPS (Basic)(per share)	-4.45	1.17	0.33	-1.61	-2.68	-7.18	-3.21	-3.91	-0.52	2.19	2.02	1.68
EPS (Diluted)(per share)	-4.45	1.16	0.32	-1.61	-2.68	-7.18	-3.26	-3.91	-0.52	2.17	2.00	1.66
Shares Outstanding (Basic, Weighted)(shares)	55	54	54	53	51	49	48	48	48	26	27	28
Shares Outstanding (Diluted, Weighted)(shares)	55	55	54	53	51	49	48	48	49	27	27	28
EBITDA	–	–	–	–	–	–	–	–	–	95	86	83

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 68.1%
Operating margin: 12.7%
Net margin: 12.8%
Return on equity, FY2025: -19.2%

Financial strength

Current ratio: 1.45
Debt to equity: 0.22
Debt to assets: 11.1%
Cash to current liabilities: 73.1%

Valuation

P/E ratio: 23.1
Price to sales: 2.99
Price to book: 3.32
Dividend yield: –